Isojamaicin, one of the isoflavonoids from Millettia griffoniana Baill (Fabaceae) has anticancer effect on human prostate cancer cells
-
Jordan Lembe Tonga
and
Derek Tantoh Ndinteh
Abstract
Objectives
The incidence of cancer, a second leading cause of death globally, continues to rise steadily, and could reach 28.4 million cases by 2040, if no action is taken. Prostate cancer, the second most common cancer in men globally following lung cancer, accounted for 1,414,259 new cases and led to 375,304 deaths in 2022. Chemotherapy and surgery remain the major treatments however, they are associated with side effects. In this study, the anticancer potentials of ten (10) isoflavonoids from Millettia griffoniana Bail was explored.
Methods
Anti-cell growth (MTT), proliferative (CCK-8) and clonogenic effects of these isoflavonoids were investigated. Furthermore, the most potent compound (isojamaicin) was investigated for its potential to induce apoptosis, inhibit cell migration/invasion and cell adhesion.
Results
Out of the 10 isoflavonoids isolated from M. griffoniana, isojamaicin significantly inhibited PC3 and LNCaP cell growth and proliferation in a concentration dependent manner. It also significantly (p<0.001) inhibited PC3 cell clone formation. It induced a potent (near 40 %) increment of apoptotic cell population in PC3 cells at both 30 and 60 μg/mL; which was followed by a notable increase in caspase-3 activity. Isojamaicin induced potent inhibition of PC3 cell invasion/migration and increased adhesion of PC3 cells to the extracellular matrix (collagen).
Conclusions
This study provides an unprecedented report of the anti-prostate cancer potential of isojamaicin and its possible underlying mechanisms. It merits further in vivo research to support the in vitro findings.
Funding source: Organisation for the Prohibition of Chemical Weapons
Award Identifier / Grant number: OPCW 188/22 1/3 INS
Acknowledgments
This study received support from the OPCW (Organization for the Prohibition of Chemical Weapons) under Grant No. OPCW 188/22 1/3 INS, awarded to Prof. Dr. Stephane Zingue.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: NDT, ZS, MME, YE and ND designed the experiments. TLJ, KKHM, RNR, TFM, YE and NDT performed the phytochemistry part of this work. ZS and ND performed the in vitro experiments. TLJ, KKHM and ZS analyzed the data. TLJ, KKHM and ZS wrote the paper and all authors read and approved the manuscript.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: The authors declare no conflict of interest.
-
Research funding: Prof. Dr. Stephane Zingue was Granted OPCW (reference # OPCW 188/22 1/3 INS).
-
Availability of data and materials: The data and materials utilized in this study are accessible upon request from the authors.
-
Consent for publication: All authors consent the publication of this manuscript on this journal.
References
1. Siegel, RL, Miller, KD, Jemal, A. Cancer statistics 2016. CA Cancer J Clin 2016;66:7–30. https://doi.org/10.3322/caac.21332.Search in Google Scholar PubMed
2. Bray, F, Laversanne, M, Sung, H, Ferlay, J, Siegel, RL, Soerjomataram, I, et al.. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229–263. https://doi.org/10.3322caac.21834.10.3322/caac.21834Search in Google Scholar PubMed
3. Ferlay, J, Ervik, M, Lam, F, Laversanne, M, Colombet, M, Mery, L, et al.. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/today [Accessed 10 Sep 2024].Search in Google Scholar
4. Bray, F, Parkin, DM, African Cancer Registry Network. Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol 2022;23:719–28. https://doi.org/10.1016/S1470-2045(22)00270-4.Search in Google Scholar PubMed
5. Arnold, M, Morgan, E, Rumgay, H, Mafra, A, Singh, D, Laversanne, M, et al.. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 2022;66:15–23. https://doi.org/10.1016/j.breast.2022.08.010.Search in Google Scholar PubMed PubMed Central
6. Pace, LE, Shulman, LN. Breast cancer in sub-Saharan Africa: challenges and opportunities to reduce mortality. Oncologist 2016;21:739–44. https://doi.org/10.1634/theoncologist.2015-0429.Search in Google Scholar PubMed PubMed Central
7. Erfani, P, Bhangdia, K, Stauber, C, Mugunga, JC, Pace, LE, Fadelu, T. Economic evaluations of breast cancer care in low and middle-income countries: a scoping review. Oncologist 2021;26:1406–17. https://doi.org/10.1002/onco.13841.Search in Google Scholar PubMed PubMed Central
8. Aizawa, K, Liu, C, Tang, S, Veeramachaneni, S, Hu, K-Q, Smith, DE, et al.. Tobacco carcinogen induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation. Int J Cancer 2016;139:1171–81. https://doi.org/10.1002/ijc.30161.Search in Google Scholar PubMed PubMed Central
9. Poon, SL, McPherson, JR, Tan, P, Teh, BT, Rozen, SG. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med 2014;6:24. https://doi.org/10.1186/gm541.Search in Google Scholar PubMed PubMed Central
10. Cumberbatch, MG, Cox, A, Teare, D, Catto, JW. Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and metaanalysis. JAMA Oncol 2015;1:1282–90. https://doi.org/10.1001/jamaoncol.2015.3209.Search in Google Scholar PubMed
11. Antwi, SO, Eckert, EC, Sabaque, CV, Leof, RE, Hawthorne, MK, Bamlet, WR, et al.. Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer. Cancer Causes Control 2015;26:1583–91. https://doi.org/10.1007/s10552-015-0652-y.Search in Google Scholar PubMed PubMed Central
12. Parkin, DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030–44. https://doi.org/10.1002/ijc.21731.Search in Google Scholar PubMed
13. Seto, M, Honma, K, Nakagawa, M. Diversity of genome profiles in malignant lymphoma. Cancer Sci 2010;101:573–8. https://doi.org/10.1111/j.1349-7006.2009.01452.x.Search in Google Scholar PubMed PubMed Central
14. Danaei, G, Vander Hoorn, S, Lopez, AD, Murray, CJ, Ezzati, M. Comparative Risk Assessment collaborating group (cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784–93. https://doi.org/10.1016/S0140-6736(05)67725-2.Search in Google Scholar PubMed
15. Blackadar, CB. Historical review of the causes of cancer. World J Clin Oncol 2016;7:54–86. https://doi.org/10.5306/wjco.v7.i1.54.Search in Google Scholar PubMed PubMed Central
16. Ansari, KK, Jha, A. Causes of cancer in the world: comparative risk assessment of nine behavioral and environmental risk factors. Cureus 2022;14:e28875. https://doi.org/10.7759/cureus.28875.Search in Google Scholar PubMed PubMed Central
17. Kingham, TP, Alatise, OI, Vanderpuye, V, Casper, C, Abantanga, FA, Kamara, TB, et al.. Treatment of cancer in sub-Saharan Africa. Lancet Oncol 2013;14:158–67. https://doi.org/10.1016/s1470-2045(12)70472-2.Search in Google Scholar
18. Banzouzi, JT, Prost, A, Rajemiarimirabo, M, Ongoka, P. Traditional uses of African Millettia species (Fabaceae). Inter J Bot 2008;4:406–20. https://doi.org/10.3923/ijb.2008.406.420.Search in Google Scholar
19. Desta, KT, Abd El-Aty, AM. Millettia isoflavonoids: a comprehensive review of structural diversity, extraction, isolation, and pharmacological properties. Phytochem Rev 2023;22:275–308. https://doi.org/10.1007/s11101-022-09845-w.Search in Google Scholar PubMed PubMed Central
20. Zingue, S, Tchoumtchoua, J, Ntsa, DM, Sandjo, LP, Cisilotto, J, Magne, NCB, et al.. Estrogenic and cytotoxic potentials of compounds isolated from Millettia macrophylla Benth. (Fabaceae): towards a better understanding of its underlying mechanisms. BMC Complement Altern Med 2016;16:1–17. https://doi.org/10.1186/s12906-016-1385-5.Search in Google Scholar PubMed PubMed Central
21. Yankep, E, Fomum, ZT, Bisrat, D, Dagne, E, Hellwig, V, Steglich, W. O-geranylated isoflavones and a 3-phenylcoumarin from Millettia griffoniana. Phytochemistry 1998;49:2521–3. https://doi.org/10.1016/s0031-9422(98)00392-6.Search in Google Scholar
22. Yankep, E, Mbafor, JT, Fomum, ZT, Steinbeck, C, Messanga, BB, Nyasse, B, et al.. Further isoflavonoid metabolites from Millettia griffoniana (Bail). Phytochemistry 2001;56:363–8. https://doi.org/10.1016/s0031-9422(00)00400-3.Search in Google Scholar PubMed
23. Yankep, E, Njamen, D, Fotsing, MT, Fomum, ZT, Mbanya, JC, Giner, RM, et al.. An isoflavone with anti-inflammatory activity from the root bark of Millettia griffoniana. J Nat Prod 2003;66:1288–90. https://doi.org/10.1021/np0205912.Search in Google Scholar PubMed
24. Ngamga, D, Yankep, E, Tane, P, Bezabih, M, Ngadjui, BT, Fomum, ZT, et al.. Isoflavonoids from seeds of Millettia griffoniana (Bail), 15*. Z Naturforsch 2005;60:973–7. https://doi.org/10.1515/znb-2005-0911.Search in Google Scholar
25. Ketcha Wanda, GJM, Njamen, D, Yankep, E, Tagatsing, FM, Tanee, FZ, Wober, J, et al.. Estrogenic properties of isoflavones derived from Millettia griffoniana. Phytomedicine 2006;13:139–45. https://doi.org/10.1016/j.phymed.2005.06.003.Search in Google Scholar PubMed
26. Rebe, RN, Lembe, JT, Nyayi, SDG, Ngatanko, HHA, Wado, EK, Ketcha Wanda, GJM, et al.. Estrogenic and anti-amnesic potential of Millettia griffoniana Baill. (Fabaceae) ethanolic extract on scopolamine-induced memory impairment in ovariectomized Wistar rats. J Ethnopharmacol 2023;39:116325. https://doi.org/10.1016/j.jep.2023.116325.Search in Google Scholar PubMed
27. Dhyani, P, Quispe, C, Sharma, E, Bahukhandi, A, Sati, P, Attri, DC, et al.. Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell Int 2022;22. https://doi.org/10.1186/s12935-022-02624-9.Search in Google Scholar PubMed PubMed Central
28. Liskova, A, Samec, M, Koklesova, L, Brockmueller, A, Zhai, K, Abdellatif, B, et al.. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. EPMA J 2021;12:155–76. https://doi.org/10.1007/s13167-021-00242-5.Search in Google Scholar PubMed PubMed Central
29. Newman, DJ, Cragg, GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 2020;83:770–803. https://doi.org/10.1021/acs.jnatprod.9b01285.Search in Google Scholar PubMed
30. Kuete, V, Efferth, T. African flora has the potential to fight multidrug resistance of cancer. BioMed Res Int 2015;2015:1–24. https://doi.org/10.1155/2015/914813.Search in Google Scholar PubMed PubMed Central
31. Shu, L, Cheung, KL, Khor, TO, Chen, C, Kong, AN. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev 2010;29:483–502. https://doi.org/10.1007/s10555-010-9239-y.Search in Google Scholar PubMed
32. Bouabdallah, S, Al-Maktoum, A, Amin, A. Steroidal saponins: naturally occurring compounds as inhibitors of the hallmarks of cancer. Cancers 2023;15:3900. https://doi.org/10.3390/cancers15153900.Search in Google Scholar PubMed PubMed Central
33. Naksuriya, O, Daowtak, K, Tima, S, Okonogi, S, Mueller, M, Toegel, S, et al.. Hydrolyzed flavonoids from Cyrtosperma johnstonii with superior antioxidant, antiproliferative, and anti- inflammatory potential for cancer prevention. Molecules 2022;27:3226. https://doi.org/10.3390/molecules27103226.Search in Google Scholar PubMed PubMed Central
34. Buyinza, D, Yang, LJ, Derese, S, Ndakala, A, Coghi, P, Heyden-reich, M, et al.. Cytotoxicity of isoflavones from Millettia dura. Nat Prod Res 2021;35:2744–7. https://doi.org/10.1080/14786419.2019.1660335.Search in Google Scholar PubMed
35. Kim, EC, Yun, BS, Ryoo, IJ, Min, JK, Won, MH, Lee, KS, et al.. Complestatin prevents apoptotic cell death: inhibition of a mitochondrial caspase pathway through AKT/PKB activation. Biochem Biophys Res Commun 2004;313:193–204. https://doi.org/10.1016/j.bbrc.2003.11.104.Search in Google Scholar PubMed
36. Steeg, PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895–904. https://doi.org/10.1038/nm1469.Search in Google Scholar PubMed
37. Sharmila, G, Bhat, FA, Arunkumar, R, Elumalai, P, Raja Singh, P, Senthilkumar, K, et al.. Chemopreventive effect of quercetin, a natural dietary flavonoid on prostate cancer in in vivo model. Clin Nutr 2014;33:718–26. https://doi.org/10.1016/j.clnu.2013.08.011.Search in Google Scholar PubMed
© 2025 Walter de Gruyter GmbH, Berlin/Boston
